WallStSmart

Kraft Heinz Co (KHC)vsArcadia Biosciences Inc (RKDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kraft Heinz Co generates 525121% more annual revenue ($24.99B vs $4.76M). KHC leads profitability with a -23.1% profit margin vs -195.9%. KHC earns a higher WallStSmart Score of 61/100 (C+).

KHC

Buy

61

out of 100

Grade: C+

Growth: 4.0Profit: 4.5Value: 7.0Quality: 4.5
Piotroski: 4/9Altman Z: 0.69

RKDA

Hold

38

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.7Quality: 5.3
Piotroski: 3/9Altman Z: -62.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KHCUndervalued (+16.4%)

Margin of Safety

+16.4%

Fair Value

$29.90

Current Price

$22.58

$7.32 discount

UndervaluedFair: $29.90Overvalued
RKDAUndervalued (+37.9%)

Margin of Safety

+37.9%

Fair Value

$2.80

Current Price

$1.03

$1.77 discount

UndervaluedFair: $2.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KHC3 strengths · Avg: 8.7/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

PEG RatioValuation
0.998/10

Growing faster than its price suggests

Operating MarginProfitability
20.7%8/10

Strong operational efficiency at 20.7%

RKDA2 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

EPS GrowthGrowth
28.5%8/10

Earnings expanding 28.5% YoY

Areas to Watch

KHC4 concerns · Avg: 2.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

Return on EquityProfitability
-13.7%2/10

ROE of -13.7% — below average capital efficiency

Altman Z-ScoreHealth
0.692/10

Distress zone — elevated risk

Profit MarginProfitability
-23.1%1/10

Currently unprofitable

RKDA4 concerns · Avg: 2.5/10
Market CapQuality
$1.94M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-323.1%2/10

ROE of -323.1% — below average capital efficiency

Revenue GrowthGrowth
-8.3%2/10

Revenue declined 8.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : KHC

The strongest argument for KHC centers on Price/Book, PEG Ratio, Operating Margin. PEG of 0.99 suggests the stock is reasonably priced for its growth.

Bull Case : RKDA

The strongest argument for RKDA centers on Price/Book, EPS Growth.

Bear Case : KHC

The primary concerns for KHC are Revenue Growth, Return on Equity, Altman Z-Score.

Bear Case : RKDA

The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

RKDA carries more volatility with a beta of 0.50 — expect wider price swings.

KHC is growing revenue faster at 0.8% — sustainability is the question.

KHC generates stronger free cash flow (766M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KHC scores higher overall (61/100 vs 38/100). RKDA offers better value entry with a 37.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kraft Heinz Co

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

The Kraft Heinz Company (KHC), commonly known as Kraft Heinz, is an American food company formed by the merger of Kraft Foods and Heinz, co-headquartered in Chicago, Illinois, and Pittsburgh, Pennsylvania.

Arcadia Biosciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.

Visit Website →

Want to dig deeper into these stocks?